참고문헌 (19)

1. Cancer Res. G. W. Bazill 50 7505 1990 Bazill, G. W. and Dexter, T. M., Role of endocytosis in the action of ether lipids on WEHI-3B, HL6O and FDCP-Mix A4Cells, Cancer Res., 50, 7505-7512 (1990). 

   상세보기

2. Eur. J. Cancer W. E. Berdel 16 1199 1980 10.1016/0014-2964(80)90179-6 Berdel, W. E., Bausert, W. R., Weltzien H. U., Modolell M. L., Widmann, K. H. and Munder, P. G., The influence of alkyl lysophospholipids and alkyl lysophospholipid-activated macrophages on the development of metastasis of 3-lewis lung carcinoma,Eur. J. Cancer, 16, 1199-1204 (1980). 

   상세보기

3. W. E. Berdel 449 1987 10.1007/978-1-4684-5284-6_21 Platelet-activating factor and related lipid mediators Berdel, W. E. and Munder, P. G., Antitumor Analogs of PAF, In Snyder, F. (Ed).Platelet-activating factor and related lipid mediators. Plenum Press, New York, 1987, pp. 449-467. 

   

4. Br. J. Cancer W. E. Berdel 64 208 1991 10.1038/bjc.1991.277 Berdel, W. E., Membrane-interactive lipids as experimental anticancer drugs.Br. J. Cancer, 64, 208-211 (1991). 

   상세보기

5. Syn. Commu. C. Botteghi 12 25 1982 10.1080/00397918208080062 Botteghi, C., Chelucci, G. and Marchetti, M.,Syn. Commu., 12, 25-33 (1982). 

   상세보기

6. Cancer Res. C. Dive 51 799 1990 Dive, C., Watson, J. V. and Workman, P., Multiparametric flow cytometry of the modulation of tumor cell membrane permeability by developmental antitumor ether lipid SRI 62-834 in EMT6 mouse mammary tumor and HL6O human promyelocytic leukemia cells.Cancer Res., 51, 799-806 (1990). 

7. J. Org. Chem. W. J. Houlihan 47 5177 1982 10.1021/jo00147a027 Houlihan, W. J. and Parrino, V. A., Directed lithiation of 2-phenyl-and 2-(o-methylphenyl)imidazoline.J. Org. Chem., 47, 5177-5180 (1982). 

   상세보기

8. J. Med. Chem. W. J. Houlihan 36 3098 1993 10.1021/jm00073a008 Houlihan, W. J., Cheon, S. H., Parrino, V. A., Handley, D. A. and Larson, D. A., Structural modification of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinoline platelet activating factor receptor antagonists.J. Med. Chem., 36, 3098-3102 (1993). 

   상세보기

9. J. Med. Chem. W. J. Houlihan 38 234 1995 10.1021/jm00002a004 Houlihan, W. J., Munder, P. G., Handley, D. A., Cheon, S. H. and Parrino, V. A., Antitumor activity of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinolines.J. Med. Chem., 38, 234-240 (1995a). 

   상세보기

10. Med. Res. Rev. W. J. Houlihan 15 157 1995 10.1002/med.2610150302 Houlihan, W. J., Lohmeyer, M., Workman, P. and Cheon, S. H., Phospholipid antitumor agents.Med. Res. Rev., 15, 157-223 (1995b). 

    상세보기

11. Arzneim.-Forsch./Drug Res. W. J. Houlihan 45 II 1133 1995 Houlihan, W. J., Munder, P. G., Handley, D. A. and Nemecek, G. A., Priclinical pharmacology and possible mechanism of action of the novel antitumor agent 5-(4′-piperidinomethylphenyl)-2,3-dihydroimidazo [2,1-a]isoquinoline.Arzneim.-Forsch./Drug Res., 45(II), 1133-1137 (1995c). 

12. E. J. Modest 330 1989 The Pharmacological effect of lipids III, Role of Lipids in Cancer Research Modest, E. J., Berens, M. E., Piantadosi, C. and Noseda, A., Pharmacological effects and anticancer activity of new ether phospholipid analogs, In Kabara J. J. (Ed).The Pharmacological effect of lipids III, Role of Lipids in Cancer Research. The American Oil Chemists' Society, Champaign, IL, 1989, pp. 330-337. 

13. P. G. Munder 206 1990 10.1159/000318979 1939-1989:Fifty Years Progress in Allergy Munder, P. G. and Westphal, O., Antitumoral and other biomedical activities of synthetic ether lysophospholipids. In Waksman, B. H. (Ed). 1939-1989:Fifty Years Progress in Allergy. Karger, New York, 1990, pp. 206-235. 

    

14. Org. Synth. Coll. C. R. Noller 11 586 1943 Noller, C. R.,Org. Synth. Coll. Vol. 11, 586-588 (1943). 

15. Biochim. Biophys. Acta A. Noseda 945 92 1988 10.1016/0005-2736(88)90366-5 Noseda, A., Godwin, P. L. and Modest, E. J., Effects of antineoplastic ether lipids on model and biological membranes.Biochim. Biophys. Acta, 945, 92-100 (1988). 

    상세보기

16. J. Org. Chem. G. S. Poindexter 47 3787 1982 10.1021/jo00140a047 Poindexter, G. S.,J. Org. Chem., 47, 3787-3788 (1982). 

    상세보기

17. Cancer Res. M. J. Seewald 50 4458 1990 Seewald, M. J., Olsen, R. A., Sehgal, I., Melder, D. C., Modest, E. J. and Powis, G., Inhibition of growth factor-dependent inositol phosphate Ca2+ signaling by antitumor ether lipid analogues.Cancer Res., 50, 4458-4463 (1990). 

    상세보기

18. Cancer Res. F. Uberall 51 807 1991 Uberall, F., Oberhuber, H., Maly, K., Zaknun, J., Demuth, L. and Grunicke, H. H., Hexadecylphosphocholine inhibits inositol phosphate formation and protein kinase C activity.Cancer Res., 51, 807-812 (1991). 

    상세보기

19. Cancer Cells P. Workman 3 315 1991 Workman, P., Antitumor ether lipids: endocytosis as a determination of cellular sensitivity.Cancer Cells, 3, 315-317 (1991). 

    상세보기

저자의 다른 논문 :

천승훈 (24) Park, Joon-Suck (1) 정병호 (23) 최보길 (24) 조원제 (24) 강부현 (32) 이정옥 (47)